登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Median time to onset of clinical signs in placebo group-PEP study.
Median time to onset of clinical signs in placebo group-PEP study.
收藏
Figshare
2017-11-23 更新
2026-04-29 收录
暴露后预防临床试验
临床终点分析
数据链接:
https://figshare.com/articles/dataset/Median_time_to_onset_of_clinical_signs_in_placebo_group-PEP_study_/5626546
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Median time to onset of clinical signs in placebo group-PEP study.
应用场景:
创建时间:
2017-11-23
相关数据集
Univariate analyses with CCS as end-point.
临床终点分析
血管疾病研究
Univariate analyses with CCS as end-point.
NIAID Data Ecosystem
6
0
Primary and secondary clinical endpoints after two weeks of nVNS and sham treatment.
神经调控疗效评估
临床终点分析
Primary and secondary clinical endpoints after two weeks of nVNS and sham treatment.
NIAID Data Ecosystem
4
0
Incidence of endpoints by randomisation group.
心血管临床试验
临床终点分析
Cardiac endpoints included fatal and non-fatal myocardial infarction, fatal and non-fatal heart failure, and sudden death. Significance was derived from the log-rank test.
NIAID Data Ecosystem
3
0
Clinical characteristics of patients who reached the primary study endpoint compared to patients who did not.
临床终点分析
患者特征比较
Clinical characteristics of patients who reached the primary study endpoint compared to patients who did not.
NIAID Data Ecosystem
6
0
Rate of incident MACE per 100 patient years by average achieved on-treatment LDL-D levels in patients with ASCVD with and without comorbidities in a pooled analysis of alirocumab Phase 3a trials.
心血管药物疗效评估
临床终点分析
(RTF)
NIAID Data Ecosystem
3
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广